Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-09-23
2008-10-21
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S218000, C514S253070, C540S575000, C544S363000
Reexamination Certificate
active
07439243
ABSTRACT:
Disclosed are quinoline compounds of formula (I) having pharmacological activity, processes for their preparation, compositions containing them, and methods for the treatment of CNS and other disorders.
REFERENCES:
patent: 6313126 (2001-11-01), Meagher et al.
patent: 2003/0013708 (2003-01-01), Haeberlein et al.
patent: 2004/0024210 (2004-02-01), Johansson et al.
patent: WO 03/035061 (2003-05-01), None
patent: WO 03/080580 (2003-10-01), None
Robichaud et al. in Annual Reports in Medicinal Chemistry, vol. 36, p. 11-20 (2000).
Rogers et al. Psychopharmacology, vol. 158, p. 114-119 (2001).
Bromidge et al. Bioorganic & Medicinal Chemistry Letters, vol. 11, p. 55-58 (2001).
Ahmed et al. Bioorganic & Medicinal Chemistry Letters vol. 15, p. 4867-4871 (2005).
Heal et al. Pharmacology & Therapeutics, vol. 117, p. 207-231 (2008).
Woolley et al.Neuropharmacology, vol. 41: 210-219 (2001).
Mitchell et al.,Pharmacol. &Therapeutics, 108: 320-333 (2005).
Chuang et al.,Alzheimer's&Dementia, The Journal of the Alzheimer's Association, 2(3/Supp. 1): S631-S632 (2006).
London Stock Exchange Announcement—GlaxoSmithKline (GSK) plc, Issued on Thursday, Dec. 13, 2007, New York, New York.
A Dose Ranging Study to Investigate the Efficacy and Safety of SB-742457 in Alzheimer's Disease. NCT ID No. NCT00224497 (Verified 2007).
SB-742457 and Donepezil in Alzheimer's Disease. NCT ID No. NCT00348192 (2006).
Garcia-Alloza et al.Neuropsychopharmacology, 29: 410-416 (2004).
Johnson Christopher Norbert
Moss Stephen Frederick
Witty David R
Bernhardt Emily
Glaxo Group Limited
Kinzig Charles M.
McCarthy Mary E.
Sieburth Kathryn L.
LandOfFree
Piperazinyl-quinoline derivatives useful for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazinyl-quinoline derivatives useful for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazinyl-quinoline derivatives useful for the treatment... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4004487